Canada is lobbying the U.S. to show its commitment to border security to avoid tariffs. Officials shared videos of border ...
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
WASHINGTON (AP) — US regulators approve new type of pain drug designed to eliminate the risks of addiction associated with opioids.